Spo0A differentially regulates toxin production in evolutionarily diverse strains of Clostridium difficile

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Mackin, Kate E ^a   Carter, Glen P ^a   Howarth, Pauline ^a   Rood, Julian I ^a   Lyras, Dena ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; PROTEIN SPO0A; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CELL VIABILITY; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; GERMINATION; MOLECULAR BIOLOGY; MOLECULAR EVOLUTION; NONHUMAN; PHYLOGENY; PLASMID; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN FUNCTION; SPOROGENESIS; TOXIN SYNTHESIS; TRANSPOSON;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; CONJUGATION, GENETIC; ENTEROTOXINS; FLAGELLA; GENE ORDER; MUTATION; PLASMIDS; RIBOTYPING;

EID: 84891929627     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079666     Document Type: Article

References (59)

1. Borriello SP (1998) Pathogenesis of Clostridium difficile infection. J Antimicrob Chemother 41: 13-19.
2. Keel MK, Songer JG (2006) The comparative pathology of Clostridium difficile-associated disease. Vet Pathol 43: 225-240.
3. Keessen EC, Gaastra W, Lipman LJ (2011) Clostridium difficile infection in humans and animals, differences and similarities. Vet Microbiol 153: 205-217.
4. Voth DE, Ballard JD (2005) Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 18: 247-263. (Pubitemid 40548293)
5. Aktories K (2011) Bacterial protein toxins that modify host regulatory GTPases. Nat Rev Microbiol 9: 487-498.
6. Burns DA, Minton NP (2011) Sporulation studies in Clostridium difficile. J Microbiol Methods 87: 133-138.
7. Gerding DN, Muto CA, Owens RC, Jr. (2008) Measures to control and prevent Clostridium difficile infection. Clin Infect Dis 46 Suppl 1: S43-49. (Pubitemid 351323664)
8. Fawcett P, Eichenberger P, Losick R, Youngman P (2000) The transcriptional profile of early to middle sporulation in Bacillus subtilis. Proc Natl Acad Sci U S A 97: 8063-8068. (Pubitemid 30460773)
9. Poncet S, Dervyn E, Klier A, Rapoport G (1997) Spo0A represses transcription of the cry toxin genes in Bacillus thuringiensis. Microbiology 143 (Pt 8): 2743-2751. (Pubitemid 27389960)
10. Paredes-Sabja D, Sarker N, Sarker MR (2011) Clostridium perfringens tpeL is expressed during sporulation. Microb Pathog 51: 384-388.
11. Huang IH, Waters M, Grau RR, Sarker MR (2004) Disruption of the gene (spo0A) encoding sporulation transcription factor blocks endospore formation and enterotoxin production in enterotoxigenic Clostridium perfringens type A. FEMS Microbiol Lett 233: 233-240. (Pubitemid 38452625)
12. Rosenbusch KE, Bakker D, Kuijper EJ, Smits WK (2012) C. difficile 630Δerm Spo0A regulates sporulation, but does not contribute to toxin production, by direct high-affinity binding to target DNA. PLoS One 7: e48608.
13. Underwood S, Guan S, Vijayasubhash V, Baines SD, Graham L, et al. (2009) Characterization of the sporulation initiation pathway of Clostridium difficile and its role in toxin production. J Bacteriol 191: 7296-7305.
14. Deakin LJ, Clare S, Fagan RP, Dawson LF, Pickard DJ, et al. (2012) The Clostridium difficile spo0A Gene is a persistence and transmission factor. Infect Immun 80: 2704-2711.
15. Warny M, Pepin J, Fang A, Killgore G, Thompson A, et al. (2005) Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366: 1079-1084. (Pubitemid 41338761)
16. McDonald LC, Killgore GE, Thompson A, Owens RC, Jr., Kazakova SV, et al. (2005) An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353: 2433-2441. (Pubitemid 41770164)
17. Pepin J, Valiquette L, Cossette B (2005) Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 173: 1037-1042.
18. Goorhuis A, Bakker D, Corver J, Debast SB, Harmanus C, et al. (2008) Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 47: 1162-1170.
19. Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, et al. (2010) The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 23: 529-549.
20. Jhung MA, Thompson AD, Killgore GE, Zukowski WE, Songer G, et al. (2008) Toxinotype V Clostridium difficile in humans and food animals. Emerg Infect Dis 14: 1039-1045. (Pubitemid 351920432)
21. Keel K, Brazier JS, Post KW, Weese S, Songer JG (2007) Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species. J Clin Microbiol 45: 1963-1964. (Pubitemid 46933933)
22. Stabler RA, Dawson LF, Valiente E, Cairns MD, Martin MJ, et al. (2012) Macro and micro diversity of Clostridium difficile isolates from diverse sources and geographical locations. PLoS One 7: e31559.
23. Dingle KE, Griffiths D, Didelot X, Evans J, Vaughan A, et al. (2011) Clinical Clostridium difficile: clonality and pathogenicity locus diversity. PLoS One 6: e19993.
24. Carter GP, Douce GR, Govind R, Howarth PM, Mackin KE, et al. (2011) The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile . PLoS Pathog 7: e1002317.
25. Lyras D, O'Connor JR, Howarth PK, Sambol SP, Carter GP, et al. (2009) Toxin B is essential for virulence of Clostridium difficile. Nature 458: 1176-1179.
26. Pospiech A, Neumann B (1995) A versatile quick-prep of genomic DNA from gram-positive bacteria. Trends Genet 11: 217-218.
27. O'Connor JR, Lyras D, Farrow KA, Adams V, Powell DR, et al. (2006) Construction and analysis of chromosomal Clostridium difficile mutants. Mol Microbiol 61: 1335-1351. (Pubitemid 44215431)
28. Sambrook J, Russell DW (2001) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
29. Heap JT., Pennington OJ., Cartman ST., Carter GP., Minton, NP (2007) The ClosTron: a universal gene knock-out system for the genus Clostridium . J Microbiol Methods 70: 452-464. (Pubitemid 47302149)
30. Anagnostopoulos C, Spizizen J (1961) Requirements for Transformation in Bacillus Subtilis. J Bacteriol 81: 741-746.
31. Carter GP, Awad MM, Hao Y, Thelen T, Bergin IL, et al. (2011) TcsL is an essential virulence factor in Clostridium sordellii ATCC 9714. Infect Immun 79: 1025-1032.
32. Reynolds CB, Emerson JE, de la Riva L, Fagan RP, Fairweather NF (2011) The Clostridium difficile cell wall protein CwpV is antigenically variable between strains, but exhibits conserved aggregation-promoting function. PLoS Pathog 7: e1002024.
33. Roberts AP, Hennequin C, Elmore M, Collignon A, Karjalainen T, et al. (2003) Development of an integrative vector for the expression of antisense RNA in Clostridium difficile. J Microbiol Methods 55: 617-624. (Pubitemid 37361088)
34. Nakano MM, Zuber P (1998) Anaerobic growth of a "strict aerobe" (Bacillus subtilis) . Annu Rev Microbiol 52: 165-190.
35. Sebaihia M, Wren BW, Mullany P, Fairweather NF, Minton N, et al. (2006) The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet 38: 779-786. (Pubitemid 43980598)
36. Hammitt MC, Bueschel DM, Keel MK, Glock RD, Cuneo P, et al. (2008) A possible role for Clostridium difficile in the etiology of calf enteritis. Vet Microbiol 127: 343-352. (Pubitemid 351173516)
37. Goorhuis A, Debast SB, van Leengoed LA, Harmanus C, Notermans DW, et al. (2008) Clostridium difficile PCR ribotype 078: an emerging strain in humans and in pigs? J Clin Microbiol 46: 1157; author reply 1158.
38. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, et al. (2011) Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377: 63-73.
39. Dawson LF, Valiente E, Faulds-Pain A, Donahue EH, Wren BW (2012) Characterisation of Clostridium difficile biofilm formation, a role for Spo0A. PLoS One 7: e50527.
40. Dupuy B, Sonenshein A (1998) Regulated transcription of Clostridium difficile toxin genes. Mol Microbiol 27: 107-120. (Pubitemid 28022581)
41. Lopez D, Vlamakis H, Kolter R (2009) Generation of multiple cell types in Bacillus subtilis. FEMS Microbiol Rev 33: 152-163.
42. Paredes CJ, Alsaker KV, Papoutsakis ET (2005) A comparative genomic view of clostridial sporulation and physiology. Nat Rev Microbiol 3: 969-978. (Pubitemid 43078160)
43. Janvilisri T, Scaria J, Thompson AD, Nicholson A, Limbago BM, et al. (2009) Microarray identification of Clostridium difficile core components and divergent regions associated with host origin. J Bacteriol 191: 3881-3891.
44. Stabler RA, Gerding DN, Songer JG, Drudy D, Brazier JS, et al. (2006) Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J Bacteriol 188: 7297-7305. (Pubitemid 44547635)
45. Mattick JS (2002) Type IV pili and twitching motility. Annu Rev Microbiol 56: 289-314.
46. Harshey RM (2003) Bacterial motility on a surface: many ways to a common goal. Annu Rev Microbiol 57: 249-273.
47. Saujet L, Monot M, Dupuy B, Soutourina O, Martin-Verstraete I (2011) The key sigma factor of transition phase, SigH, controls sporulation, metabolism, and virulence factor expression in Clostridium difficile. J Bacteriol 193: 3186-3196.
48. Scaria J, Ponnala L, Janvilisri T, Yan W, Mueller LA, et al. (2010) Analysis of ultra low genome conservation in Clostridium difficile. PLoS One 5: e15147.
49. Stabler RA, He M, Dawson L, Martin M, Valiente E, et al. (2009) Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol 10: R102.
50. Awad MM, Rood JI (1997) Isolation of α-toxin, θ-toxin and κ-toxin mutants of Clostridium perfringens by Tn916 mutagenesis. Microb Pathog 22: 275-284. (Pubitemid 27223877)
51. Rood JI (1983) Transferable tetracycline resistance in Clostridium perfringens strains of porcine origin. Can J Microbiol 29: 1241-1246.
52. Zhao Y, Melville SB (1998) Identification and characterization of sporulation-dependent promoters upstream of the enterotoxin gene (cpe) of Clostridium perfringens. J Bacteriol 180: 136-142. (Pubitemid 28023793)
53. Hall IC, Scott AL (1931) The Serologic Agglutination of Bacillus sordellii and Clostridium oedematoides. J Bacteriol 22: 375-385.
54. Ballard J, Bryant A, Stevens D, Tweten R (1992) Purification and characterization of the lethal toxin (alpha toxin) of Clostridium septicum. Infect Immun 60: 784-790.
55. Carter GP, Lyras D, Allen DL, Mackin KE, Howarth PM, et al. (2007) Binary toxin production in Clostridium difficile is regulated by CdtR, a LytTR family response regulator. J Bacteriol 189: 7290-7301. (Pubitemid 47557343)
56. Lyerly DM, Barroso LA, Wilkins TD, Depitre C, Corthier G (1992) Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun 60: 4633-4639.
57. Mullany P, Wilks M, Lamb I, Clayton C, Wren B, et al. (1990) Genetic analysis of a tetracycline resistance element from Clostridium difficile and its conjugal transfer to and from Bacillus subtilis. J Gen Microbiol 136: 1343-1349. (Pubitemid 20238472)
58. Perelle S, Gibert M, Bourlioux P, Corthier G, Popoff M (1997) Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196. Infect Immun 65: 1402-1407. (Pubitemid 27146631)
59. Hussain HA, Roberts AP, Mullany P (2005) Generation of an erythromycin-sensitive derivative of Clostridium difficile strain 630 (630Δerm) and demonstration that the conjugative transposon Tn 916DE enters the genome of this strain at multiple sites. J Med Microbiol 54: 137-141. (Pubitemid 40867997)